The market share of surplus lines insurers has grown considerably. We examine the impact of surplus lines representation within insurer groups on the extent of product diversification. Initial evidence suggests that groups with greater surplus lines representation are more diversified than other groups. These results hold when controlling for the joint impact of surplus lines representation and size, as well as surplus lines representation and the percentage of overall business written in personal lines. However, when examining the subsample of groups affiliated with surplus lines insurers, we find some evidence that supports the product focus hypothesis, which states surplus lines insurers are used to further focus on existing product lines already being written by other members of the group.
The Patient Protection and Affordable Care Act (ACA) was designed to increase the accessibility and affordability of health insurance. While the ACA did not contain direct provisions related to workers’ compensation (WC), because health‐related coverage is a significant portion of WC costs, the ACA could have unintentionally impacted the WC market. Specifically, expanded health insurance enrollment could reduce WC losses and result in higher performance among insurers participating in the WC market. Using insurer‐state level data, we consider the impact of increased health insurance enrollment on the performance of property‐casualty (PC) insurers. Utilizing multiple measures of performance, we find that the post‐ACA period is generally associated with greater profitability for PC insurers operating in the WC market, a positive unintended consequence of this federal regulation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.